Effect of Oral Combination Therapy of Metformin Extended Release Over Glimepiride in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus With Failure of Monotherapy.
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Glimepiride/metformin (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Laboratorios Silanes
- 10 Jun 2017 Biomarkers information updated
- 20 May 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 20 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.